| |
Overall (N = 258)
|
Control (N = 62)
|
Snus trial (N = 64)
|
Nicorette trial (N = 67)
|
Ariva trial (N = 65)
|
Offered and tried the ST product (N = 115)
|
Offered but did not try the ST product (N = 81)
|
|---|
|
Race–white
|
65 %
|
66 %
|
67 %
|
66 %
|
60 %
|
68 %
|
59 %
|
|
Race–black
|
28 %
|
31 %
|
23 %
|
27 %
|
32 %
|
27 %
|
28 %
|
|
Race–other
|
7 %
|
3 %
|
9 %
|
7 %
|
8 %
|
5 %
|
12 %
|
|
Age–under 30 yearsb
|
38 %
|
27 %
|
36 %
|
39 %
|
51 %
|
44 %
|
38 %
|
|
Age–30 to 50 years
|
38 %
|
35 %
|
41 %
|
36 %
|
38 %
|
39 %
|
37 %
|
|
Age–over 50 yearsb
|
24 %
|
37 %
|
23 %
|
25 %
|
11 %
|
17 %
|
25 %
|
|
Female
|
44 %
|
39 %
|
41 %
|
51 %
|
45 %
|
38 %c
|
55 %
|
|
Income–below 30 K
|
57 %
|
56 %
|
63 %
|
49 %
|
58 %
|
54 %
|
60 %
|
|
Income–between 30 and 60 K
|
10 %
|
19 %
|
09 %
|
10 %
|
11 %
|
14 %
|
14 %
|
|
Income–over 60 K
|
15 %
|
10 %
|
11 %
|
13 %
|
17 %
|
10 %
|
10 %
|
|
Income–chose not to reveal
|
18 %
|
15 %
|
17 %
|
27 %
|
14 %
|
22 %
|
16 %
|
|
Moderately or very worried about future quality of life
|
61 %
|
61 %
|
59 %
|
64 %
|
58 %
|
62 %
|
59 %
|
|
Prior smokeless tobacco use
|
43 %
|
39 %
|
50 %
|
43 %
|
38 %
|
55 %c
|
28 %
|
|
Observations–NY
|
36 %
|
39 %
|
33 %
|
36 %
|
38 %
|
38 %
|
30 %
|
|
Observations–SC
|
34 %
|
35 %
|
36 %
|
37 %
|
29 %
|
32 %
|
37 %
|
|
Observations–PA
|
29 %
|
26 %
|
31 %
|
27 %
|
32 %
|
30 %
|
31 %
|
-
aAuctions conducted from November 2010–November 2011
-
bThe only demographic characteristics that differed across treatment groups at a significance level of 0.05 or less was the over 50 age group (p < 0.01). No other differences in demographic characteristics were found to be significant at the 5 % level using a chi-squared test
-
cThe only demographic or background characteristics where there were statistically significant differences in the percentage who tried ST products was for females (p < 0.05) and for those who had used smokeless tobacco at some point in the past (p < 0.01)
